This IDC Survey examines Big Data analytics (BDA) and artificial intelligence (AI) trends among European life sciences organizations. The study analyzes adoption and investment plans for analytic technologies across five application areas pertaining to BDA and AI use cases: optimization of business processes, regulatory compliance, patient experience transformation, R&D analytics and clinical data transformation, and optimization of sales and marketing. Where applicable, comparative analyses of the results are presented by subregion (Western Europe and CEE) and the three subindustries of pharmaceuticals, medical devices, and clinical R&D organizations.
The data analyzed in this document comes from the life sciences sample of IDC's European Vertical Markets Survey, 2018–2019. The sample consists of 127 respondents in 13 European countries. IDC's European Vertical Markets Survey is a major annual study of IT solutions, investment priorities, and emerging technologies. This year, the sample encompassed more than 77% of the European economy (in terms of GDP), including the Russian, Polish, and Czech markets.
The European life sciences industry is increasingly recognizing the need for more routinely and effectively leveraging this data for both day-to-day operations and strategic decision making.
"As growing data volumes accumulate from a broadening set of applications and collaboration networks that generate and use the data, the European life sciences industry is increasingly recognizing the need for more routinely and effectively leveraging data for day-to-day operations and strategic decision making across various business areas. European life sciences organizations have already recognized the potential of BDA in revolutionizing research and development and advancing personalized medicine. Western European companies are also taking their first steps to leverage AI in order to add efficiencies to R&D and sales and marketing efforts, while also experimenting with AI applications to support customer and patient engagement initiatives," said Nino Giguashvili, senior research analyst, IDC Health Insights Europe.